Article
Analysis of pre-chemotherapy WBC, PLT, monocyte, hemoglobin, and MPV levels in acute myeloid leukemia patients with WT1, FLT3, or NPM gene mutations.
Medicine - 1 Apr 2020
Merdin Alparslan, Dal Mehmet Sinan, Çakar Merih Kizil, Yildiz Jale, Ulu Bahar Uncu, Batgi Hikmetullah, Tetik Ayşegül, Seçilmiş Sema, Darçin Tahir, Şahin Derya, Bakirtaş Mehmet, Başçi Semih, Yiğenoğlu Tuğçe Nur, Baysal Nuran Ahu, İskender Dicle, Altuntaş Fevzi
Abstract excerpt
Effects of mutations on AML (acute myeloid leukemia) patients have been an area of clinical interest. The aim of this study was to analyze pre-chemotherapy WBC (white blood cell), platelet, monocyte, hemoglobin, and mean platelet volume (MPV) levels in acute myeloid leukemia patients with Wilms tumor 1 (WT1), FMS-like tyrosine kinase 3 (FLT3), or nucleophosmin (NPM) gene mutations, attempting to detect and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.